LeonaBio, Inc. Earnings Per Share, Basic and Diluted
LeonaBio, Inc. (LONA) reported Earnings Per Share, Basic and Diluted of -$0.65 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-15
- LeonaBio, Inc. earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$0.65.
- LeonaBio, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.56.
- LeonaBio, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.44.
- LeonaBio, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.42.
- LeonaBio, Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.49.
- LeonaBio, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.67.
- LeonaBio, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.45.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | -$0.65 10-Q · filed 2022-08-15 | -$1.20 10-Q · filed 2022-08-15 | -$1.64 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.06 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||
| 2022-03-31 | -$0.56 10-Q · filed 2022-05-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.42 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.79 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||
| 2021-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.86 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.23 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.49 10-K · filed 2022-03-28 | ||
| 2021-09-30 | -$0.42 10-Q · filed 2021-11-10 | -$0.80 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.05 10-K · filed 2022-03-28 | -$1.12 10-Q · filed 2021-11-10 | -$1.30 derived: net income ÷ weighted average shares · filed 2022-11-10 | |
| 2021-06-30 | -$0.38 10-Q · filed 2022-08-15 | -$0.63 10-Q · filed 2022-08-15 | -$0.68 10-Q · filed 2021-08-16 | -$0.87 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.38 derived: net income ÷ weighted average shares · filed 2022-11-10 | |
| 2021-03-31 | -$0.25 10-Q · filed 2022-05-12 | -$0.49 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.99 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.35 derived: net income ÷ weighted average shares · filed 2022-11-10 | ||
| 2020-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2022-03-28 | -$0.81 derived: net income ÷ weighted average shares · filed 2022-03-28 | -$1.23 derived: net income ÷ weighted average shares · filed 2022-03-28 | -$1.67 10-K · filed 2022-03-28 | ||
| 2020-09-30 | -$1.12 10-Q · filed 2021-11-10 | -$1.79 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$2.38 10-Q · filed 2021-11-10 | -$2.78 derived: net income ÷ weighted average shares · filed 2021-11-10 | ||
| 2020-06-30 | -$0.48 10-Q · filed 2021-08-16 | -$0.96 10-Q · filed 2021-08-16 | -$1.25 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.68 derived: net income ÷ weighted average shares · filed 2021-11-10 | ||
| 2020-03-31 | -$0.48 10-Q · filed 2021-05-13 | -$0.76 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.18 derived: net income ÷ weighted average shares · filed 2021-11-10 | |||
| 2019-12-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.70 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$1.45 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$0.43 10-Q · filed 2020-11-12 | -$1.18 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |